INSIGHTS ON CLINICAL TRIAL DESIGN

• Unanticipated Roadblocks In Ovarian Cancer Drug Development

  Ovarian cancer trials require specialized strategies that go beyond generic tumor designs. Enhance your program by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

• Evolution Of ERP In Biotech And Integration Challenges

  Consolidating various software systems enables efficient management of direct fees, pass-throughs, and investigator grants within a single platform, providing a complete view of your trials' financial health.

• Rethinking Alzheimer's Trial Recruitment And Why It Can't Wait

  Alzheimer's trials face urgent recruitment challenges. Data-driven strategies, digital tools, and community engagement can accelerate enrollment and improve retention in this complex therapeutic space.

• Master Protocols: Implementing Effective Treatment Adaptations

  From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  12/20/2024

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• Retention Begins With Recruiting The Right-Fit Patients

  11/13/2025

  Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

• Eligibility Criteria For Successful Retinal Study Delivery

  1/14/2026

  Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.

• The Importance Of A Maturity Model For Clinical Trial Transparency

  10/23/2024

  A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.

• EDC Powers End-To-End Data Management In Pharma-Sponsored Trials

  9/4/2025

  As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.